Molecular imaging of bacterial outer membrane vesicles based on bacterial surface display

Abstract

The important roles of bacterial outer membrane vesicles (OMVs) in various diseases and their emergence as a promising platform for vaccine development and targeted drug delivery necessitates the development of imaging techniques suitable for quantifying their biodistribution with high precision. To address this requirement, we aimed to develop an OMV specific radiolabeling technique for positron emission tomography (PET). A novel bacterial strain (E. coli BL21(DE3) ΔnlpI, ΔlpxM) was created for efficient OMV production, and OMVs were characterized using various methods. SpyCatcher was anchored to the OMV outer membrane using autotransporter-based surface display systems. Synthetic SpyTag-NODAGA conjugates were tested for OMV surface binding and 64Cu labeling efficiency. The final labeling protocol shows a radiochemical purity of 100% with a ~ 29% radiolabeling efficiency and excellent serum stability. The in vivo biodistribution of OMVs labeled with 64Cu was determined in mice using PET/MRI imaging which revealed that the biodistribution of radiolabeled OMVs in mice is characteristic of previously reported data with the highest organ uptakes corresponding to the liver and spleen 3, 6, and 12 h following intravenous administration. This novel method can serve as a basis for a general OMV radiolabeling scheme and could be used in vaccine- and drug-carrier development based on bioengineered OMVs.

Engineered Microorganisms for Advancing Tumor Therapy

“…Outer membrane vesicles (OMVs) can be naturally produced by many bacterial species and maintain many of the same components as the outer membrane of the parent bacteria. [ 73 ] In one example, Gujrati et al. first purified bioengineered OMVs (Affi HER2 OMVs) from the parent bacteria and then encapsulated the small interfering RNAs (siRNAs) inside the membrane via electroporation to obtain the siRNA‐loaded OMVs (Affi HER2 OMV siRNA ).…”